Sage Journals: Discover world-class research

Retricted access

Research article

First published 2008-06

Adalimumab Therapy for Refractory Uveitis: A Pilot Study

Manuel Diaz-Llopis, Salvador García-Delpech, David Salom [...]

Journal of Ocular Pharmacology and Therapeutics

Retricted access

Research article

First published 2009-12

Can Adalimumab Make a Smooth and Easy Transition from Cyclosporine a Reality? A Case Series of Successful Transitions

Shilpa Gattu, Jashin J. Wu, John Y.M. Koo

Journal of Psoriasis and Psoriatic Arthritis®

Open access

Review article

First published 2024

Golimumab and certolizumab pegol for the treatment of hidradenitis suppurativa: a literature review and future perspective

Amirhossein Heidari, Yekta Ghane, Nazila Heidari [...]

Sage Open Chronic Disease

Free access

Review article

First published 2019-12

Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses

Katerina Pantavou, Anneza I Yiallourou, Daniele Piovani [...]

United European Gastroenterology Journal

Retricted access

Research article

First published 2019-5

Combination Therapies for Hidradenitis Suppurativa: A Retrospective Chart Review of 31 Patients

Meghan L. McPhie, Alanna C. Bridgman, Mark G. Kirchhof

Journal of Cutaneous Medicine and Surgery

Retricted access

Research article

First published 2018-7

Prescription Pattern Variability of Biologic Therapies in Treating Psoriasis

Emily Galli, Guodong Liu, Doug Leslie [...]

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Research article

First published 2014-2

Reporting on Adverse Clinical Events

Clin-Alert

Open access

Case report

First published 2022

Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review

Vanesa Calvo-Río, Lara Sánchez-Bilbao, Carmen Álvarez-Reguera [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2024

Carriage of the HLA-DQA1⋆05 haplotype is associated with a higher risk of infratherapeutic drug concentration and higher immunogenicity in patients undergoing treatment with anti-TNF for inflammatory bowel disease

Pilar Navajas Hernández, Samer Mouhtar el Halabi, Ana Caridad González Parra [...]

Therapeutic Advances in Gastroenterology

Search results